Skip to main content
OpenTrials

Clinical trial condition

Tick-Borne Diseases

Explore clinical trials studying Tick-Borne Diseases. Study availability and eligibility vary by location and protocol.

129 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Tick-Borne Diseases trial results

Completed

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

NCT00840801

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Unterer Graben 2 Eferding, Upper Austria, Austria
  • Grieskirchnerstr.17 Wels, Upper Austria, Austria
  • Private surgery of General Practitioner for children and juveniles Havlíčkův Brod, Czechia
  • University Hospital Hradec Kralove, Vaccinal center, Clinic of infectious diseases, Sokolská 581 Hradec Králové, Czechia
View Trial Details
Completed

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

NCT04648241

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Medical Co. LTA PS Clinic Fukuoka, Japan
  • Azuma kodomo katei clinic Ebetsu Shi, Hokkaido, Japan
  • Watanabe Pediatric Allergy Clinic Sapporo, Hokkaido, Japan
  • Ohigesenseino Kodomo Clinic Sapporo, Hokkaido, Japan
View Trial Details
Completed

Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis

NCT03970733

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +7 more
Locations
  • Clinical Research Consulting, LLC Milford, Connecticut, United States
  • Stamford Therapeutics Consortium Stamford, Connecticut, United States
  • United Medical Associates Binghamton, New York, United States
  • Regional Clinical Research, Inc Endwell, New York, United States
View Trial Details
Completed

Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis

NCT03010228

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +12 more
Locations
  • eStudy Site La Mesa, California, United States
  • eStudySite La Mesa, California, United States
  • Celerion Inc. Lincoln, Nebraska, United States
  • Celerion, Inc Lincoln, Nebraska, United States
View Trial Details
Completed

Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

NCT03769194

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +7 more
Locations
  • Clinical Research Consulting, LLC Milford, Connecticut, United States
  • Stamford Therapeutics Consortium Stamford, Connecticut, United States
  • United Medical Associates Binghamton, New York, United States
  • Regional Clinical Research, Inc. Endwell, New York, United States
View Trial Details

Related conditions